Enteroviral meningoencephalitis after anti-CD20 (Rituximab) treatment

Clinical infectious diseases: An official publication of the Infectious Diseases Society of America

Volumn 36, Issue 3, 2003, Pages e47-49

  Quartier, Pierre ^a   Tournilhac, Olivier ^b   Archimbaud, Christine ^c   Lazaro, Leila ^d   Chaleteix, Carine ^b   Millet, Pascale ^e   Peigue Lafeuille, Hélène ^c   Blanche, Stéphane ^a   Fischer, Alain ^a   Casanova, Jean Laurent ^a   Travade, Philippe ^b   Tardieu, Marc ^e  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Service d Hématologie   (France)

^c Centre Hospitalo Universitaire   (France)

^d RENNES UNIVERSITY HOSPITAL   (France)

^e BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD20 ANTIGEN; MONOCLONAL ANTIBODY; RITUXIMAB;

ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CHILD; HUMAN; IMMUNOLOGY; MENINGOENCEPHALITIS; MIDDLE AGED;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; ANTINEOPLASTIC AGENTS; CHILD; HUMANS; MENINGOENCEPHALITIS; MIDDLE AGED;

EID: 0037318312     PISSN: None     EISSN: 15376591     Source Type: Journal    
DOI: 10.1086/345746     Document Type: Article

References (0)